DOJ wants J&J's Gorsky to testify on Risperdal; Pfizer Zoloft suits returned to state court in Missouri;

@FiercePharma: Lilly chief: We can't cut our way out of this mess. Need new drugs, new sales, too--Bloomberg. Article | Follow @FiercePharma

> The Department of Justice wants Alex Gorsky, who was just elevated to CEO at Johnson & Johnson ($JNJ), to provide a deposition in a whistleblower case alleging the company paid kickbacks to the Omnicare nursing home pharmacy to prescribe Risperdal antipsychotic more often. Story

> A federal judge has ordered that a lawsuit against Pfizer ($PFE), filed on behalf of 21 children born with birth defects and whose mothers had taken Zoloft when pregnant, be returned to state court in St. Louis, where it was originally filed. Story

> British drug maker AstraZeneca ($AZN) says it has begun marketing Dutoprol, a new blood pressure treatment, and it intends to sell it directly to patients and mail it to their homes. Story

> The FDA has given approval to Mylan Pharmaceuticals' ($MYL) ANDA for fluvastatin, its generic formulation of Novartis' Lescol capsules, the company says. Story

Biotech News

@FierceBiotech: Amazon hungers for genomics data after NIH pact. Story | Follow @FierceBiotech

@JohnCFierce: Another PhRMA fact from Dow Jones: 3,200 trials under way versus 2,400 in 2005. More | Follow @JohnCFierce

@RyanMFierce: An Aussie biotech, ImmunAid, has wrapped a A$1M round, monitors immune system to gauge optimal delivery time. Release | Follow @RyanMFierce

> Embattled AZ chief: Bigger R&D bets, megadeals not the answer. More

> Biopharma lobby members pumped $49.5B into R&D. Article

> Tioga nabs $10M VC deal amid PhIII for bowel disorder drug. News

Medical Devices News

@FierceMedDev: Firewall Created to safeguard against medical-device hacking | Imperial Valley News. News | Follow @FierceMedDev

> Purdue/Princeton team creates firewall for medical devices. Story

> Tornier to consolidate facilities in Europe, U.S. More

> What can St. Jude expect post-Riata? Article

> NeuroLogica, Stryker enter BodyTom pact. News

And Finally... Valeant Pharmaceuticals ($VRX) is stepping up its position in podiatry with the acquisition of Pedinol Pharmacal, a small, privately owned company that specializes in drugs and treatments used by foot doctors. Report